January 30, 2018
Precision Vaccination highlighted our cancer vaccine, TPIV200 for treating triple-negative breast cancer.
January 27, 2018
Peter Hoang, President and CEO of TapImmune, is enthusiastic about a cancer vaccine under development by TapImmune that could help prevent recurrence of such cancers in women.
January 23, 2018
With new innovations and breakthroughs in the field of immunotherapy TapImmune CEO & President, Peter Hoang has been amazed by the change of pace within the field.
January 3, 2018
TapImmune President & CEO, Peter Hoang, to present at Biotech Showcase next week.